Votrient

Glaxo scraps the ovarian cancer app for Votrient
Fierce Biotech
Mon, 03/31/14 - 11:51 am
Europe
GSK
ovarian cancer
Votrient
Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/6/13 - 09:12 am
kidney cancer
ONYX Pharmaceuticals
Bayer
Nexavar
Roche
Avastin
Inlyta
Sutent
Pfizer
Votrient
GSK
Afinitor
Novartis
BMS-936558
Bristol-Myers Squibb
tivozanib
Aveo Oncology
Are Ariad's Options Dwindling?
Motley Fool
Sun, 04/1/12 - 12:35 pm
Ariad Pharmaceuticals
ridaforolimus
Merck
GSK
Votrient
Positive Vote for Glaxo's Votrient
Yahoo/Zacks
Sat, 03/24/12 - 11:35 am
GSK
Votrient
sarcoma
FDA panel recommends Glaxo's Votrient for sarcoma
Yahoo/Reuters
Wed, 03/21/12 - 10:02 am
FDA
advisory panel
Votrient
sarcoma
GSK
An FDA Advisory Panel Doubleheader
Motley Fool
Tue, 03/20/12 - 10:07 am
FDA
advisory panels
Votrient
soft tissue sarcomas
GSK
Merck
ridaforolimus
Ariad Pharmaceuticals
FDA Staff Questions Benefits of Glaxo, Merck Cancer Drugs
Bloomberg
Fri, 03/16/12 - 11:22 am
GSK
Merck
FDA
Ariad Pharmaceuticals
ridaforolimus
Votrient
GSK pitches Votrient rebate if trial favors Sutent
Fierce Pharma
Wed, 12/29/10 - 10:50 am
GSK
Sutent
Votrient
cancer
GSK gets conditional marketing nod in EU for pazopanib to treat RCC
Pharmabiz
Thu, 06/17/10 - 09:50 am
GSK
Votrient
renal cell carcinoma
GSK Receives Positive Opinions In Europe For Tyverb® (lapatinib) And Votrient™ (pazopanib)
Medical News Today
Sat, 02/20/10 - 11:52 am
GSK
Tyverb
Votrient
breast cancer
Glaxo cancer drugs given European greenlight
Yahoo/AP
Fri, 02/19/10 - 10:28 am
GSK
Europe
Tykerb
Votrient
FDA approves GlaxoSmithKline renal cancer drug
Marketwatch
Tue, 10/20/09 - 07:41 am
GSK
renal cancer
FDA
Votrient